Friday, September 23, 2011
Whether the campaign by the California Institute for Regenerative Medicine results in a new bond measure to supplement the $3 billion guarantee provided by Proposition 71’s passage in 2004 is an open question. Leaders of the San Francisco-based agency say they have not decided whether to ask voters to extend funding past 2017, when Prop. 71 money stops.
One thing, however, is sure: Many patients, advocacy groups and scientific researchers are eager to become both preacher and choir.